Literature DB >> 25271312

Stem cell transplants for myelodysplastic syndromes: refining the outcome predictions.

Austin John Barrett1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25271312      PMCID： PMC4181248          DOI： 10.3324/haematol.2014.113555

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

Review 1.  Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation.

Authors:  Katayoun Rezvani; A John Barrett
Journal:  Best Pract Res Clin Haematol       Date:  2008-09       Impact factor: 3.020

2.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

3.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

4.  Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.

Authors:  Brian L McClune; Daniel J Weisdorf; Tanya L Pedersen; Gisela Tunes da Silva; Martin S Tallman; Jorge Sierra; John Dipersio; Armand Keating; Robert P Gale; Biju George; Vikas Gupta; Theresa Hahn; Luis Isola; Madan Jagasia; Hillard Lazarus; David Marks; Richard Maziarz; Edmund K Waller; Chris Bredeson; Sergio Giralt
Journal:  J Clin Oncol       Date:  2010-03-08       Impact factor: 44.544

5.  International scoring system for evaluating prognosis in myelodysplastic syndromes.

Authors:  P Greenberg; C Cox; M M LeBeau; P Fenaux; P Morel; G Sanz; M Sanz; T Vallespi; T Hamblin; D Oscier; K Ohyashiki; K Toyama; C Aul; G Mufti; J Bennett
Journal:  Blood       Date:  1997-03-15       Impact factor: 22.113

6.  Specific abnormalities versus number of abnormalities and cytogenetic scoring systems for outcome prediction after allogeneic hematopoietic SCT for myelodysplastic syndromes.

Authors:  C Kelaidi; I Tzannou; I Baltadakis; I Batsis; D Mallouri; A Spyridonidis; S Gigantes; P Tsirigotis; I Apostolidis; A Athanasiadou; K Manola; A Anagnostopoulos; N Harhalakis; I Sakellari; D Karakasis
Journal:  Bone Marrow Transplant       Date:  2014-05-05       Impact factor: 5.483

7.  Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R.

Authors:  Matteo G Della Porta; Emilio Paolo Alessandrino; Andrea Bacigalupo; Maria Teresa van Lint; Luca Malcovati; Cristiana Pascutto; Michele Falda; Massimo Bernardi; Francesco Onida; Stefano Guidi; Anna Paola Iori; Raffaella Cerretti; Paola Marenco; Pietro Pioltelli; Emanuele Angelucci; Rosi Oneto; Francesco Ripamonti; Paolo Bernasconi; Alberto Bosi; Mario Cazzola; Alessandro Rambaldi
Journal:  Blood       Date:  2014-02-20       Impact factor: 22.113

Review 8.  At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies.

Authors:  Franco Locatelli; Pietro Merli; Sergio Rutella
Journal:  J Leukoc Biol       Date:  2013-10-04       Impact factor: 4.962

Review 9.  Optimizing outcomes following allogeneic hematopoietic progenitor cell transplantation in AML: the role of hypomethylating agents.

Authors:  Massimo Martino; Roberta Fedele; Tiziana Moscato; Francesca Ronco
Journal:  Curr Cancer Drug Targets       Date:  2013-07       Impact factor: 3.428

10.  Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working Party.

Authors:  Francesco Onida; Ronald Brand; Anja van Biezen; Michel Schaap; Peter A von dem Borne; Johan Maertens; Dietrich W Beelen; Enric Carreras; Emilio P Alessandrino; Liisa Volin; Jürgen H E Kuball; Angela Figuera; Jorge Sierra; Jürgen Finke; Nicolaus Kröger; Theo de Witte
Journal:  Haematologica       Date:  2014-08-01       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.